Description

The Hepatic Fibrosis Test YRA317 and YRA321 are advanced diagnostic tools designed to enable the early detection of liver fibrosis. Recognizing the potential for the complete reversal of early hepatic fibrosis, these tests play a crucial role in improving patient outcomes and quality of life. The tests are compatible with the Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, which ensures high precision and reliability in monitoring liver health. The availability of multiple models, each targeting specific parameters like PIIINP, CIV, LN, HA, and CG, allows healthcare providers to tailor their approach based on individual patient needs.

Market Price

In the competitive market of biochemical diagnostics, the Hepatic Fibrosis Test YRA317 and YRA321 are priced to offer excellent value. The price range typically varies based on the specific model and its capacity, generally ranging from $200 to $500 per kit. For precise pricing, we invite you to generate a quote through our integrated platform, Kalstein Plus, where you can explore competitive offers and evaluate the best option for your practice.

Frequently Asked Questions

What is the importance of early hepatic fibrosis detection? Early detection allows for timely medical intervention, which can halt or reverse the progression of the disease, potentially preventing cirrhosis.

Are the tests easy to use? Yes, designed for ease of use with Chemiluminescence Immunoassay Analyzers, these tests offer straightforward procedures that integrate seamlessly into clinical workflows.

Advantages and Disadvantages

The primary advantage of the Hepatic Fibrosis Test YRA317 and YRA321 is their precision and reliability in early liver fibrosis detection. They are also CE, ISO13485, and FSC certified, ensuring compliance with international standards. However, a possible disadvantage is the need for specific compatible analyzers, which may require clinics to upgrade their current systems if they’re not already in use.

Product Use in the Field

In practical applications, these tests are utilized extensively in hospitals and specialized liver treatment centers. They are essential in the routine monitoring of patients with risk factors for liver disease, providing actionable insights swiftly, which allows healthcare professionals to adjust treatment plans accordingly.

Recommendations

For optimal use, it is recommended to store the kits at temperatures between 2-8°C. Regular calibration, as specified (2/6 Points), ensures the accuracy and reliability of test results. Engaging with the Kalstein Plus platform is recommended to manage your purchase and explore additional products that complement liver disease management.

Features

• Early detection of hepatic fibrosis
• Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390
• Certified CE, ISO13485, FSC
• Storage: 2-8°C
• Calibration: 2/6 Points
• Advanced diagnostic parameters: PIIINP, CIV, LN, HA, CG

Technical Specifications